Sign Up For Free
  • Post Time Posted March 26, 2019
Zimbabwe recently authorized licences to grow cannabis for medical or research purposes. Previously, it was illegal to possess, consume or cultivate the plant, with violations leading to harsh penalties of up to 12 years in prison. Now, after many delays in the implementation of the regulations, licensed companies and individuals can grow the plant.

Earlier this month, the country approved the licence for its first medical cannabis company, Precision Cannabis Therapeutics Zimbabwe, at the cost of approximately $61,700 (CAD).

Zimbabwe is the second country on the continent of Africa to have legalized the cultivation of cannabis, with Lesotho having begun to issue cultivation licences in 2017. The latter country has enjoyed major financial and economic benefits as a result of the legislation.

Licences are to be renewed every five years, and permits authorized growers to grow, sell, possess and transport cannabis flower and oil.

Candidates must disclose plans for quantity, sales, production period and the site, itself, upon applying for a licence. The government has stated that applicants who are deemed to be a risk to public health and safety will not be authorized to cultivate.

Some Zimbabweans are saying that one of the risks to public health and safety is the fact that growers must pay a significant fee in order to be permitted to grow cannabis commercially. Critics allege that the cost will block poor farmers from transitioning to legal growing in areas that already produce large amounts of illicit cannabis, such as Binga.

“If people are growing tobacco and are not paying any licence fees, then people should not pay $50,000 for producing cannabis because it will be exported for foreign currency,” Uzumba MP Simbaneuta Medarikawa told the Zimbabwe Mail.

The drug also faces social stigma. In a recent piece from Bulawayo 24 News, the author alleged that the new cultivation regulations were “a move set to create an industry likely to lure a breed of high-risk, high-return investors,” and repeatedly expresses “concerns that this might result in an increase in cannabis use and associated harms,” such as psychosis.

Although cannabis continues to be referred to as a “dangerous drug” in Zimbabwe, it is estimated that Zimbabwe’s cannabis market could be worth over $7 billion (US) by 2023.

Source: https://www.thegrowthop.com/cannabis-news/zimbabwe-authorizes-licence-to-first-medical-cannabis-company-but-drug-remains-controversial

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.


Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.